Homeyahoo-finance2
Cytokinetics Inc
Indicative price
$62.31
Nov 3, 2026
1
Funds holding
$98.9M
Reported value
1,160,888
Reported shares
Company profile
Stage
Country
Mark dateNov 3, 2026
Price history
Price per share in USD
Nov 3, 2026O $62.74H $64.37L $62.05C $62.31
Current funds holding Cytokinetics Inc
| Fund | Manager | As of | Shares | Fair value | % of fund | AUM |
|---|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF TCAF | T. Rowe Price | Jun 30, 2026 | 1,160,888 | $98,896,049 | 1.3% | $7.4B |
Published ownership history
Historical positions are grouped by fund and accepted SEC portfolio snapshot.
| Fund | As of | Filing | Shares | Fair value | % of fund |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2026 | NPORT-P | 1,160,888 | $98,896,049 | 1.3% |
| T. Rowe Price Capital Appreciation Equity ETF | Mar 31, 2026 | NPORT-P | 1,045,102 | $68,882,673 | 1.1% |
| T. Rowe Price Capital Appreciation Equity ETF | Dec 31, 2025 | NPORT-P | 1,372,972 | $87,238,641 | 1.4% |
| T. Rowe Price Capital Appreciation Equity ETF | Sep 30, 2025 | NPORT-P | 1,211,702 | $66,595,142 | 1.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2025 | NPORT-P | 729,638 | $24,107,240 | 0.5% |
| T. Rowe Price Capital Appreciation Equity ETF | Mar 31, 2025 | NPORT-P | 212,815 | $8,553,035 | 0.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Dec 31, 2024 | NPORT-P | 89,282 | $4,199,825 | 0.1% |